Enovix Sinks 28.66% After Dropping Smartphone Tests and Guiding Q4 Sales Below Q3
Enovix reported a record gross margin and 38% revenue growth, but also dropped smartphone field testing and guided Q4 sales below Q3. Shares fell 28.66% and were up 5.26% in after-hours trading.

Enovix Corporation (NASDAQ: ENVX) closed at $1.81 on Thursday, Nov. 12, down 28.66% from Wednesday, after its third-quarter results came out before the open. The company, which filed an 8-K at 7:44 a.m. ET, said revenue rose 38% to $11.0 million. It also dropped system-level smartphone field testing and guided fourth-quarter sales to $9.0 million to $10.0 million.
A record margin met a smartphone setback and a lower Q4 range
Enovix reported a record non-GAAP gross margin (profit after production costs, excluding items such as stock compensation) and guided 2027 revenue to $65 million to $85 million, which the company said is nearly double expected 2026 revenue at the midpoint. The same release said its pre-AI-2 smartphone cells missed the latest energy-density target, and the Q4 sales range sits below Q3's $11.0 million. The stock fell in both the pre-market and regular sessions, and the company did not say which item mattered more.
Shares fell in both sessions, then bounced after the close
In pre-market trading (the session before the 9:30 a.m. open), the stock fell to $2.26, down 10.67% from Wednesday's close of $2.53. About 1.32 million shares traded, in a range of $2.10 to $2.63. The high was above Wednesday's close, and it is not clear whether it came before the 7:44 a.m. filing.
The regular session took off another 20.13% from the pre-market close. About 21.88 million shares changed hands, against a 10-day average of about 6.92 million a day. That volume equals 11.3% of the 193.8 million-share float (the shares available to trade). The intraday low was $1.79.
In after-hours trading (the session after the 4 p.m. close), shares were at $1.90 at 4:58 p.m. ET, up 5.26% from the close on about 200,000 shares. That is still 24.9% below Wednesday's close.
Before Thursday, the stock had gained 3.69% from Oct. 14 through Nov. 11, with a high of $3.57 on Oct. 29. It fell 13.98% to $2.40 on Nov. 5 and jumped 15% to $2.76 on Nov. 6. It then closed at $2.78, $2.64 and $2.53 over the next three sessions. Thursday's close was below the period's low of $2.19.
What the company said about smartphones and Q4
The company said its AI-1 smartphone cells passed its own cell-level qualification testing. That version was built on the pre-AI-2 process and did not meet the latest energy-density target of more than 1,000 watt-hours per liter. The company decided not to proceed with system-level field testing and is concentrating silicon-anode development on smart eyewear, where it has a backlog. Its lead smartphone customer is expected to finish its own parallel qualification next week.
For the fourth quarter, the company guided sales to $9.0 million to $10.0 million and an adjusted loss of $0.13 to $0.17 a share. Third-quarter revenue was $11.0 million. For 2027, the company said nearly half the midpoint of its $65 million to $85 million guidance is already in backlog.
The company's market value is about $439 million.
Margins and drone orders improved, losses persisted
- Margins: non-GAAP gross margin was 34.5%, up 13.5 points from a year earlier. GAAP gross margin was 30.1%. The company credited a richer mix that included smart eyewear, drone and defense revenue.
- Losses: the non-GAAP loss was $0.15 a share, against $0.14 a year earlier. The GAAP loss narrowed to $0.19 from $0.27.
- Pipeline: the drone, defense and industrial pipeline grew 18% to about $216 million, with $150 million from drones. The company received an initial 100,000-battery drone order and a first production order for its MX1-B01 aerial drone cell, with deliveries scheduled for early 2027.
- Eyewear: about 19,000 units have shipped this year against a 50,000-pack backlog that the company expects to finish in the first half of 2027.
- Costs: an early-November restructuring cut 220 positions and about $8.5 million of annual cost. A $19 million project to double drone battery capacity at its South Korean facility is expected to come online in the second quarter of 2027.
- Balance sheet: cash, securities and restricted cash were $512.2 million, or $2.35 per outstanding share, as of Oct. 4. That figure precedes the October and November repurchases of notes and stock.
- Debt: since quarter end the company has retired $128.0 million face value of its 2030 convertible notes for about $81.4 million, a 36% discount. The remaining 2030 notes stand at $232.0 million. It also repurchased $15.5 million of stock in October, after $6.2 million in the third quarter.
What to watch next
- Next week: the lead smartphone customer's qualification result.
- The warrant dividend the company launched to retire its 3.00% convertible notes due 2028.
- Early 2027: initial MX1-B01 drone cell deliveries.
- First half of 2027: completion of the 50,000-pack eyewear backlog.
- Second quarter of 2027: the Korean capacity expansion coming online.
Bottom line
Revenue, gross margin and the drone order book improved in the quarter, while the smartphone plan narrowed and Q4 sales are guided below Q3. Shares closed 28.66% below Wednesday's close, and the after-hours rebound to $1.90 came with the session still open.
This article was processed by WSN Finance AI Analysis and prepared by WSN Editors based on financial analysis.
This article is for informational purposes only and is not investment advice.




